Patient journey report

1. Consultile| Uplifting Field Force Capabilities in Iraq | Proposal |
Acino | June 2021
The Journey Toward Launch Excellence

2. Consultile Middle East | Macro-economic outlook and
Pharmaceutical market overview in Egypt | March 2021
+ Consultile Capabilities
+ Launch Excellence
+ Five trends are changing the landscape of new drug launches
+ Providing a three-pillar framework for successful launch
planning
+ The Journey Toward Launch Excellence
+ Launch Process
+ The biggest challenges in launch planning for pharmaceuticals
+ Consultile Launch Excellence Services
Table of Contents

3. ABOUT US
Consultile is a consulting and Digital Marketing firm with experts
in healthcare and pharmaceutical industry.
We deliver solutions through leading-edge management
consulting along with technology. We work in a uniquely
collaborative model across the firm and throughout all levels of the
client organization, generating results that allow our clients to
thrive.
Consulting Services Technology Solutions
Our mission
is to partner with industry leaders to provide
innovative and integrated solutions to help
pharmaceutical companies take insightful strategic
decisions to grow and to adapt their strategies for
best business outcomes.
Company philosophy
Innovation and integrity are important values to our
business philosophy.

4. Consultile provides a broad range of assets and services to customers in
Life Sciences
Management Consulting
Department
Market Research Services Marketing Services Training Center
We deliver solutions through leading-edge management consulting along with technology. We work in a uniquely
collaborative model across the firm and throughout all levels of the client organization, generating results that allow our
clients to thrive.

5. Consultile Middle East | Macro-economic outlook and
Pharmaceutical market overview in Egypt | March 2021
+ Consultile Capabilities
+ Launch Excellence
+ Five trends are changing the landscape of new drug launches
+ Providing a three-pillar framework for successful launch
planning
+ The Journey Toward Launch Excellence
+ Launch Process
+ The biggest challenges in launch planning for pharmaceuticals
+ Consultile Launch Excellence Services
Table of Contents

6. Fewer
blockbusters
While companies used to launch a few large products each year,
they are now launching many small-to-mid size products instead,
with more intense competition. This growing emphasis on small-
to-medium-revenue products means that pharma companies are
developing wider and more fragmented product portfolios than
ever before. In turn, product launches increasingly need to be
tailored and customized to suit diverse product types. Additionally,
this means that there is stronger pressure for a quicker return on
investment (ROI).

7. Rise in
specialty
launches
The majority of new launches are increasingly targeted to smaller
patient populations, and around half of new drugs approved in the
US recently were specialty medicines. By their very nature, specialty
drugs require much more targeted launch efforts and a highly
customized approach, which means launch teams face a steep
learning curve. Biosimilars in particular present a new level of
complexity in the specialty market..

8. Focus on value
and outcomes
There has been a strong shift towards a greater focus on value
and outcomes, driven by the increasing importance of
functions such as Health Economics and Outcomes Research
(HEOR), managed care account management, and patient
advocacy services. Payers increasingly are putting pressure on
coverage and drug reimbursement, sometimes even
restricting access for patients.

9. As product technology development cycles have shortened over time,
companies need to continuously plan to think and stay ahead. This
dramatic acceleration of innovation means products typically have less
time on the market to recoup investment.
Acceleration of
innovation cycle

10. s3
With continuous pressures on bottom-lines, there is an
overwhelming need to ‘do more with less’. Diminishing
firm-wide launch capabilities mean launch resourcing is
often sub-optimal. Balancing speed-to-market with
proper launch preparation is putting more pressure on
resources than ever before. In such an environment,
adaptability is often the key to success.
Doing more
with less

11. A three-pillar framework for successful launch planning
A foundation of strong capabilities in each of these areas is critical to the success of the launch.
Market
A foundation of strong capabilities
Targeted market shaping activities to drive
access, uptake, adherence, and advocacy.
Leveraging insights and positioning
to optimize value to the patient
Coordinated and adequate resourcing, training,
and mobilization across functions

12. Define & Build
Process Training & Roll Out
Transform & Perform
Sustain & Improve
• In the first stage, companies need to define global, regional and country launch excellence for their organizations. Existing
materials can be leveraged to build the launch excellence framework and tools.
• Next, define a plan for launch excellence implementation and change management/communication.
• This is the most important step in building a robust foundation for launch excellence within the organization. This stage takes
time as it touches on sensitive topics and requires changes in how the organization operates in a launch mode.
• In stage two, launch excellence can be piloted with launch teams to test the process and ensure it
works. The process built in stage one may need to be refined based on the pilot studies.
• The launch excellence resources, such as framework, tools and templates, can then be rolled out
with training materials to ensure quality execution is continuously being developed.
• In stage three of the journey, ongoing launch excellence support should be provided to the
launch teams. Leaders must drive sustained launch excellence utilization, measure impact and
maintain and refine processes.
• Successes and best practices should consistently be captured and shared across the
organization
• Stage four involves managing launch excellence processes, collecting and incorporating feedback and adapting to
business-driven changes.
• Successes and best practices should continue to be shared while developing launch excellence experts to build
sustainability
The Journey Toward Launch Excellence

13. LAUNCH PROCESSES
Achieving launch excellence is a journey with multiple stages requiring constant engagement and refinement
01
Market Research
02
Planning
03
Execution
04
Launch Readiness
07
Insight
Generation
06
Launch
Tracking
08
MANAGE-
MENT
05
Excellence
Tracking
Market Research
Do you know your market?
The market research process is a
systematic method for business
decisions based on market data
analysis and results.
Planning
How to launch as planned?
The 'Planning' process handles the
activity. project and budget planning
for each product launch.
Execution
Are you progressing as planned?
Identify potential issues and ensure
that resources and funds are
prioritized efficiently.
Launch Readiness
Are you ready to launch ?
Each launch has its own
checklist and activity assessment to
measure the quality of the launch
activities.
Excellence Tracking
Are the processes being followed?
Excellence tracking is about applying
a governance on processes themselves
and define criteria for ideal usage of tools
and modules.
Launch Tracking
How is your product performing?
This is a data driven process. which should
provide answers on product uptake and
forecasting.
Insight Generation
How improve launch activities?
Insights are generated by
systematically investigation of
various data sources.

15. Challenge #1
Embedding a launch framework consistently across the company
The launch framework must be understood, accepted and applied
systematically throughout the organization, and across brands, therapy
areas, local affiliates and functional silos.
That way, companies can avoid continuously re-inventing the wheel and
diluting best practices.
A common framework will guard against difficulties such as:
▪ Information lags in launch tracking.
▪ lack of clarity over timelines, budgets or key performance indicators.
▪ Fragmentation of resources (human or otherwise).
▪ Poor co-ordination and local discrepancies.
▪ Strategic misalignment.
▪ Last-minute reversals to the pharma launch plan.

16. Challenge #2
Ensuring that key personnel are focused on strategic priorities, rather
than on time-consuming administrative distractions.
Key members of the launch team often get embroiled in
time-consuming administrative distractions, such as
chasing teams for timelines and activity status, collecting,
processing, and consolidating data, or manually preparing
reports and presentations.
A collaborative launch management platform, should
streamline and automate these tasks. In doing so, it will
save your team members time, so that they can focus on
strategy and executing with excellence
COMMUNICATION
TIME MANAGEMENT
SCHEDULING
BUDGETING
1
2
3
4
5
EXECUTE
SUPPORT
IMPLEMENT
STRATEGIZE PLAN

17. Challenge #3
Making sure you have real-time visibility of
launch readiness across the organization,
both at global and local level.
Real-time visibility of launch readiness, timelines and
status can keep these imperatives front of mind.
Chasing markets for updates, or collecting and
consolidating data from poorly aligned launch readiness
tools, may leave key personnel struggling to claw back
vital time for launch strategy and implementation.
All internal stakeholders need to be on the same page
about launch progress from market to market, regardless
of national boundaries, functional silos or position within
the organization.
Any number of local issues can bring about changes in
status and timelines that undermine careful launch
scheduling.

18. Consultile Middle East | Macro-economic outlook and
Pharmaceutical market overview in Egypt | March 2021
+ Consultile Capabilities
+ Launch Excellence
+ Five trends are changing the landscape of new drug launches
+ Providing a three-pillar framework for successful launch
planning
+ The Journey Toward Launch Excellence
+ Launch Process
+ The biggest challenges in launch planning for pharmaceuticals
+ Consultile Launch Excellence Services
Table of Contents

19. Consultile Launch Excellence S e r v i c e s
• Acceptance of KOLs for your new
products
• Acceptable price range
• Estimated Rx. share
• Performance diagnostic
• Brand excellence framework
• Super KPIs framework
• Where do your target patient diagnosed
and at which stage?
• Which specialty treat them and when do
they refer them to other specialties and
when?
• Which guidelines do physician follow
and why?
Market
understanding and
forecasting
• Develop market understanding for your
product and key competitors
• Market forecasting for next 5 years and
opportunity evaluation
• Patient epidemiology forecast including
number or patients, % of diagnosed patients
and treated patients.
Patient Journey
and Referral
Pathway
Performance
measurements
Test Value
Preposition
I II
III IV

20. Please Contact Us for More Information
Mohamed Salem
Principle Management Consulting; Middle
East
Mohamed.salem@consultile.com
+2 010 269 12348
Afnan Sabry
Business Development Manager
Afnan.sabry@consultile.com
+2 011 431 5328
Mohamed Ahmed
Principle Marketing Services; Middle East
Mohamed.ahmed@consultile.com
+2 012 739 06129